New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability

Bioconjugate Chemistry

Volumn 8, Issue 3, 1997, Pages 327-337

  Arpicco, Silvia ^a   Dosio, Franco ^a   Brusa, Paola ^a   Crosasso, Paola ^a   Cattel, Luigi ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELL CULTURE; COVALENT BONDS; PEPTIDES; SOLUTIONS; STABILITY;

COUPLING REAGENTS; CROSS-LINKING REAGENTS; DERIVATIZATIONS; DISULPHIDE BONDS; GLUTHATHIONE; IMMUNOTOXINS; METHYL GROUP; PHENYL GROUP; SYNTHESISED; THIOL-DISULFIDE EXCHANGE REACTION;

SULFUR COMPOUNDS;

EID: 0031148911     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970025w     Document Type: Article

References (38)

1. Vitetta, E. S., Thorpe, P. E., and Uhr, J. W. (1993) Immunotoxins: magic bullets or misguided missiles? Immunol. Today 14, 252-259.
2. Wawrzynczak, E. J. (1992) Rational design of immunotoxins: current progress and future prospects. Anti-Cancer Drug Des. 7, 427-441.
3. Brinkmann, U., and Pastan, I. (1994) Immunotoxins against cancer. Biochim. Biophys. Acta 1198, 27-45.
4. Carlsson, J., Drevin, H., and Axen, R. (1978) Protein thiolation and reversible protein-protein conjugation. Biochem. J. 173, 723-737.
5. Gros, O., Jansen, F. K., and Vidal, H. J. (1985) Biochemical aspects of immunotoxin preparation. J. Immunol. Methods 81, 283-297.
6. King, T. P., Li, Y., and Kochoumian, L. (1978) Preparation of protein conjugates via intermolecular disulfide bond formation. Biochemistry 17, 1499-1506.
7. Thorpe, P. E., Blakey, D. C., Brown, A. N. F., Knowles, P. P., Knyba, R. E., Wallace, P. M., Watson, G. J., and Wawrzynczak, E. J. (1987) Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants. J. Natl. Cancer Inst. 79, 1101-1111.
8. Masuho, Y., Kishida, K., Saito, M., Umemoto, N., and Hara, T. (1982) Importance of the antigen-binding valency and the nature of the cross-linking bond in ricin A-chain conjugates with antibody. J. Biochem. 91, 1583-1591.
9. Wawrzynczak, E. J., and Thorpe, P. E. (1988) Effect of chemical linkage upon the stability and cytotoxic activity of A chain immunotoxins. In Immunotoxins (A. E. Frankel, Ed.) pp 239-251, Kluwer, Boston.
10. Worrell, N. R., Cumber, A. J., Parnell, G. D., Ross, W. C., and Forrester, J. A. (1986) Fate of an antibody-ricin A chain conjugate administered to normal rats. Biochem. Pharmacol. 35, 417-423.
11. Blakey, D. C., Watson, G. J., Knowles, P. P., and Thorpe P. E. (1987) Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy1.1 antibody. Cancer Res. 47, 947-952.
12. Letvin, N. L., Goldmacher, V. S., Ritz, J., Yetz, J. M., Schlossman, S. F., and Lambert, J. M. (1986) In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. J. Clin. Invest. 77, 977-984.
13. Worrell, N. R., Cumber, A. J., Parnell, G. D., Mirza, A., Forrester, J. A., and Ross, W. C. J. (1986) Effect of linkage variation on pharmacokinetcs of ricin A chain-antibody conjugates in normal rats. Anti-Cancer Drug Des. 1, 179-188.
14. Thorpe, P. E., Wallace, P. M., Knowles, P. P., Relf, M. G., Brown, A. N. F., Watson, G. J., Knyba, R. E., Wawrzynczak, E. J., and Blakey, D. C. (1987) New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res. 47, 5924-5931.
15. Greenfield, L., Bloch, W., and Moreland, M. (1990) Thiol-containing cross-linking agent with enhanced steric hinderance. Bioconjugate Chem. 1, 400-410.
16. Carrol, S. F., Bernhard, S. L., Goff, D. A., Bauer R. J., Leach, W., and Kung, A. H. C. (1994) Enhanced stability in vitro and in vivo of immunoconjugate prepared with 5-methyl-2-iminothiolane. Bioconjugate Chem. 5, 248-256.
17. Ghetie, V., Thorpe, P., Ghetie, M. A., Knowles, P., Uhr, J. W., and Vitetta, E. S. (1991) The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond. J. Immunol. Methods 142, 223-230.
18. Amlot, P. L., Stone, M. J., Cunningham, D., Fay, J., Newman, J., Collins, R., May, R., McCarthy, M., Richardson, J., Ghetie, V., Ramilo, O., Thorpe, P. E., Uhr, J. W., and Vitetta, E. S. (1993) A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 82, 2624-2633.
19. Delprino, L., Giacomotti, M., Dosio, F., Brusa, P., Ceruti, M., Grosa, G., and Cattel, L. (1993) Toxin-targeted design for anticancer therapy. I: synthesis and biological evaluation of new thioimidate heterobifunctional reagents. J. Pharm. Sci. 82, 506-512.
20. Delprino, L., Giacomotti, M., Dosio, F., Brusa, P., Ceruti, M., Grosa, G., and Cattel, L. (1993) Toxin-targeted design for anticancer therapy. II: preparation and biological comparison of different chemically linked gelonin-antibody conjugates. J. Pharm. Sci. 82, 699-704.
21. 1.1 monoclonal antibody and the ribosome inactivating protein, gelonin. Eur. J. Biochem. 116, 447-454.
22. Prat, M., Morra, I., Bussolati, G., and Comoglio, P. M. (1985) CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas. Cancer Res. 45, 5799-5807.
23. Duncan, R. J. S., Weston, P. D., and Wrigglesworth, R. (1983) A new reagent which may be used to introduce sulfhydyl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132, 68-73.
24. Cattel, L., Delprino, L., Brusa, P., Dosio, F., Comoglio, P. M., and Prat, M. (1988) Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines. Cancer Immunol. Immunother. 27, 233-240.
25. Fraker, P .J., and Speck, J. D. (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,2,4,6-tetrachloro-3a,6a-diphenylglycouril. Biochem. Biophys. Res. Commun. 80, 849-857.
26. Dosio, F., Brusa, P., Delprino, L., Grosa, G., Ceruti, M., and Cattel, L. (1994) A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody. J. Pharm. Sci. 83, 206-211.
27. Scott, C. F. Jr., Goldmacher, V. S., Lamber, J. M., Jackson J. V., and McIntyre, G. D. (1987) An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumor. J. Natl. Cancer Inst. 79, 1163-1172.
28. Holmberg, B., and Schjamberg, E. (1940) Omattade syror och tioattiksyra. Ark. Kemi, Mineral. Geol. 40A (7), 1-10.
29. Roger, R., and Neilson, D. G. (1961) The chemistry of imidates. Chem. Rev. 61, 179-211.
30. Behforouz, M., and Kerwood, J. E. (1969) Alkyl and arykil sulfenimides. J. Org. Chem. 34, 51-55.
31. Stirpe, F., Olsnes, S., and Pihl, A. (1980) Gelonin a new inhibitor of protein synthesis, non toxic to intact cells. J. Biol. Chem. 255, 6947-6953.
32. Rosenblum, M. G., Kohr, W. A., Beattie, K. L., Beattie, W. G., Marks, W., Toman, P. D., and Cheung, L. (1995) Amino acid sequence analysis, gene construction, cloning, and expression of gelonin, a toxin derived from Gelonium multiflorum. J. Interferon Cytokine Res. 15, 547-555.
33. Lambert, J. M., Senter, P. D., Yau-Young, A., Blatter, W. A., and Goldmacher, V. S. (1985) Purified immunotoxins that are reactive with human lymphoid cells. J. Biol.Chem. 260, 12035-12041.
34. Goff, D. A., and Carroll, S. F. (1990) Substituted 2-iminothiolanes: reagents for the preparation of disulfide cross-linked conjugates with increased stability. Bioconjugate Chem. 1, 381-386.
35. Calvete, J. A., Newell, D. R., Charlton, C. J., and Wright, A. F. (1993) Pharmacokinetic studies in mice with ICI D0490, a novel recombinant ricin A-chain immunotoxin. Br. J. Cancer 67, 1310-1315.
36. Flavell, D. J., Boehm, D. A., Okayama, K., Kohler, J. A., and Flavell, S. U. (1994) Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkers. Int. J. Cancer 58, 407-414.
37. Cumber, A. J., Westwood, J. H., Henry, R. V., Parnell, G. D., Coles, B. F., and Wawrzynczak, E. J. (1992) Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins. Bioconjugate Chem. 3, 397-401.
38. Wawrzynczak, E. J., Cumber, A. J., Henry, R. V., May, J., Newell, D. R., Parnell, G. D., Worrell, N. R., and Forrester, J. A. (1990) Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Cancer Res. 50, 7519-7526.